DIA Pharmacovigilance and Risk Management Strategies Conference
Huron's drug safety and regulatory team is delighted to be exhibiting and attending this year’s DIA Pharmacovigilance and Risk Management Strategies Conference in Washington, D.C..
This year’s conference will address the current thinking on predicting and assessing the probability of risks such as drug-induced liver injury, and the assessment of expectedness of serious adverse reactions during clinical development. The complexities of assessing benefit-risk balance of today’s therapies, including immunotherapy and other advanced therapies, will also be examined. Experts will present approaches and engage in dialogue around more extensive and impactful uses of real-world data and generation of real-world evidence for safety assessments.
Come and visit us at booth #36 to meet the team. We look forward to seeing you there.
- Mark Perrott
- Contact Me